Johanna Bendell
0000-0001-9426-5891
F Hoffmann-La Roche AG Research and Development Division
2 papers found
Refreshing results…
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer
Missing publications? Search for publications with a matching author name.